| Indicators | Browse All

MediWound Ltd. (MDWD)

Healthcare | Biotechnology | Yavne, Israel | NasdaqGM
12.66 USD -0.58 (-4.381%) ⇩ (Aug. 28, 2026, 4 p.m. EDT)
After hours: 12.66

Short-term:★☆☆☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | Aug. 22, 2026, 5:09 a.m. EDT

MediWound presents a classic value trap scenario where the market's pessimism is justified by deteriorating fundamentals rather than temporary distress. The company is actively shrinking, with revenue contracting by nearly 46% year-over-year and burning through cash, resulting in a massive cumulative loss of over 69% since 2016. Despite the 'strong buy' analyst ratings and a lofty target price, these metrics reflect a business failing to generate growth or profitability, making the current valuation unjustified for a long-term holder. The stock is trading near its 52-week lows, confirming the market's rejection of the recovery narrative. For the short term, the heavy put positioning suggests traders are bracing for further declines, likely ahead of upcoming earnings, while the statistical forecast offers no directional edge. This is a speculative vehicle for high-risk capital, not a core investment.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.037638
AutoETS0.047301
AutoTheta0.048180
AutoARIMA0.064383

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 45%
H-stat 1.28
Ljung-Box p 0.000
Jarque-Bera p 0.242
Excess Kurtosis 0.17
Attribute Value
Sector Healthcare
Debt to Equity Ratio 24.142
Revenue per Share 0.957
Market Cap 163,444,112
Forward P/E -5.53
Beta 0.16
Profit Margins -170.10%
Website https://www.mediwound.com

As of Aug. 22, 2026, 5:09 a.m. EDT: Speculators are heavily positioned for downside protection, evidenced by significant put open interest at strikes just below the current price (13.0 and 14.0) and notably high volume at the 16.0 strike relative to open interest. Call activity is sparse and concentrated further out-of-the-money, indicating a lack of immediate bullish conviction despite the 'strong buy' analyst consensus.


Info Dump

Attribute Value
52 Week Change -0.23734939
Address1 42 Hayarkon Street
All Time High 135.17
All Time Low 7.1
Ask 18.25
Ask Size 2
Average Analyst Rating 1.2 - Strong Buy
Average Daily Volume10 Day 109,850
Average Daily Volume3 Month 85,238
Average Volume 85,238
Average Volume10Days 109,850
Beta 0.156
Bid 10.22
Bid Size 2
Book Value 2.761
City Yavne
Compensation As Of Epoch Date 1,767,139,200
Country Israel
Crypto Tradeable 0
Currency USD
Current Price 12.66
Current Ratio 2.316
Custom Price Alert Confidence HIGH
Date Short Interest 1,786,665,600
Day High 13.18
Day Low 12.52
Debt To Equity 24.142
Display Name MediWound
Earnings Call Timestamp End 1,786,624,200
Earnings Call Timestamp Start 1,786,624,200
Earnings Timestamp 1,786,624,200
Earnings Timestamp End 1,795,091,400
Earnings Timestamp Start 1,795,091,400
Ebitda -30,749,000
Ebitda Margins -2.5920098
Enterprise To Ebitda -4.446
Enterprise To Revenue 11.524
Enterprise Value 136,708,112
Eps Current Year -2.23
Eps Forward -2.29
Eps Trailing Twelve Months -2.07
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 14.1387
Fifty Day Average Change -1.4786997
Fifty Day Average Change Percent -0.10458527
Fifty Two Week Change Percent -23.73494
Fifty Two Week High 20.3
Fifty Two Week High Change -7.6399994
Fifty Two Week High Change Percent -0.37635466
Fifty Two Week Low 12.52
Fifty Two Week Low Change 0.13999939
Fifty Two Week Low Change Percent 0.0111820595
Fifty Two Week Range 12.52 - 20.3
Financial Currency USD
First Trade Date Milliseconds 1,395,322,200,000
Float Shares 8,872,201
Forward Eps -2.29
Forward P E -5.528384
Free Cashflow -29,048,876
Full Exchange Name NasdaqGM
Full Time Employees 121
Fullday Change -0.58
Fullday Change Percent -4.38066
Fullday Price 12.66
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.1546
Gross Profits 1,834,000
Has Pre Post Market Data 1
Held Percent Insiders 0.15958999
Held Percent Institutions 0.53613
Implied Shares Outstanding 12,910,278
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Is Earnings Date Estimate 0
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,671,494,400
Last Split Factor 1:7
Long Business Summary MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Long Name MediWound Ltd.
Market us_market
Market Cap 163,444,112
Market State CLOSED
Max Age 86,400
Message Board Id finmb_1570881
Most Recent Quarter 1,782,777,600
Net Income To Common -20,179,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 170,932,080
Number Of Analyst Opinions 6
Open 13.18
Operating Cashflow -22,136,000
Operating Margins -3.0588598
Payout Ratio 0.0
Phone 972 7 797 14100
Post Market Change 0.0
Post Market Change Percent 0.0
Post Market Price 12.66
Post Market Time 1,787,959,806
Previous Close 13.24
Price Eps Current Year -5.6771297
Price Hint 2
Price To Book 4.585295
Price To Sales Trailing12 Months 13.7776375
Profit Margins -1.7010001
Quick Ratio 2.094
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key strong_buy
Recommendation Mean 1.16667
Region US
Regular Market Change -0.58
Regular Market Change Percent -4.38066
Regular Market Day High 13.18
Regular Market Day Low 12.52
Regular Market Day Range 12.52 - 13.18
Regular Market Open 13.18
Regular Market Previous Close 13.24
Regular Market Price 12.66
Regular Market Time 1,787,947,201
Regular Market Volume 165,533
Return On Assets -0.28589
Return On Equity -0.72374
Revenue Growth -0.458
Revenue Per Share 0.957
Sand P52 Week Change 0.20204377
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 12,910,278
Shares Percent Shares Out 0.123
Shares Short 1,587,726
Shares Short Previous Month Date 1,784,073,600
Shares Short Prior Month 1,616,406
Short Name MediWound Ltd.
Short Percent Of Float 0.14050001
Short Ratio 24.32
Source Interval 15
Symbol MDWD
Target High Price 36.0
Target Low Price 22.0
Target Mean Price 29.83333
Target Median Price 30.0
Total Cash 35,341,000
Total Cash Per Share 2.737
Total Debt 8,605,000
Total Revenue 11,863,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -2.07
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 16.38345
Two Hundred Day Average Change -3.7234497
Two Hundred Day Average Change Percent -0.22726896
Type Disp Equity
Volume 165,533
Website https://www.mediwound.com
Zip 8,122,745